The Meaning Behind Value Stocks
A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples are good base indicators that the company is undervalued and can most likely be labelled as a value stock.
Below is a list of notable value stocks in the healthcare sector:
- Cullinan Oncology CGEM - P/E: 5.43
- Quantum-Si QSI - P/E: 5.0
- Innoviva INVA - P/E: 8.41
- Fulgent Genetics FLGT - P/E: 3.03
- Verve Therapeutics VERV - P/E: 5.27
This quarter, Cullinan Oncology experienced an increase in earnings per share, which was $-0.27 in Q1 and is now $3.77. Most recently, Quantum-Si reported earnings per share at $-0.23, whereas in Q1 earnings per share sat at $-0.25. Innoviva's earnings per share for Q2 sits at $0.05, whereas in Q1, they were at 0.39. Fulgent Genetics has reported Q2 earnings per share at $0.78, which has decreased by 84.65% compared to Q1, which was 5.08. This quarter, Verve Therapeutics experienced a decrease in earnings per share, which was $-0.62 in Q1 and is now $-0.84.
The Significance: A value stock may need some time to rebound from its undervalued position. The risk of investing in a value stock is that this emergence may never materialize.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.